openPR Logo
Press release

Gastrointestinal Stent Market Is At A rate of 5.5% from 2022 - 2032 | Merit Medical Systems, Cantel Medical, Taewoong Medical

12-06-2023 03:53 AM CET | Health & Medicine

Press release from: Global Insight Services

The global Gastrointestinal Stent market size was USD 467 million in 2022 and is anticipated to reach USD 796.8 million in 2032, growing at a rate of 5.5% from 2022 to 2032.

Gastrointestinal (GI) stents are made to provide palliative care for a variety of illnesses that clog the GI tract. The recanalization of gastrointestinal (GI) malignancies and postoperative leak sealing are two important functions of GI stents. Drug-eluting devices, tissue modeling for benign disorders, and GI tract drainage/anastomosis are among more possible uses for GI stents. The rise in gastrointestinal malignancies and other digestive illnesses, changing lifestyles, rising healthcare spending on gastrointestinal treatments, and growing desire for less invasive surgery are all factors contributing to the growth of the global market for gastrointestinal stents.

Download Free Sample of Report - https://www.globalinsightservices.com/request-sample/GIS10289/utm_source=pranalipawar&utm_medium=Openpr&utm_campaign=06122023

Market Trends and Drivers

The increase in the incidence of gastrointestinal cancers, IBD, and other digestive diseases is propelling the growth of the market. One of the biggest causes of death in the globe is gastrointestinal cancer. Morbidity and mortality from chronic diseases like esophageal cancer, colorectal cancer, and serious gastrointestinal disorders have sharply increased in recent years. According to the International Agency for Research on Cancer (IARC), gastrointestinal malignancies accounted for 35 percent of all cancer-related fatalities and 26 percent of the global burden of cancer incidence in 2018. The WHO estimates that stomach cancer caused 769,000 deaths worldwide in 2020, whereas gastrointestinal malignancies like colorectal cancer cause 935,000 deaths. 1.93 million new instances of colorectal cancer were detected worldwide in 2020, making it the third most frequent cancer overall.

Major Players in the Global Gastrointestinal Stent Market

The key players studied in the global gastrointestinal stent market are Boston Scientific Corporation (US), Cook Group (US), Medtronic plc. (Ireland), ELLA-CS, s.r.o. (Czech Republic), Becton, Dickinson and Company (US), Merit Medical Systems (US), CONMED Corporation (US), Cantel Medical (US), Olympus Corporation (Japan), Taewoong Medical (South Korea) among others.

COVID-19 Impact

Over 4.4 million people have been afflicted by the coronavirus, which has spread to 215 nations and territories and caused close to 300,000 deaths. The global COVID-19 outbreak has put medical practices of all sizes under a great deal of stress. A worldwide emergency has been caused by the COVID-19 pandemic. The risk of COVID-19 infection is higher for surgeons and patients who visit hospitals for various procedures. All elective procedures in Germany were either canceled or postponed because hospitals there are overflowing with COVID-19 cases. Major hospitals in Germany had to postpone between 40 and 50 percent of their endoscopic treatments.

Request Customization- https://www.globalinsightservices.com/request-customization/GIS10289/utm_source=pranalipawar&utm_medium=Openpr&utm_campaign=06122023

Major limitations on in-person consultations were enacted by numerous nations during the COVID-19 pandemic. As a result, stenting procedures were reduced in hospitals and outpatient clinics, and consultations were conducted via phone consultations, which was the most practical mode of delivery. This has had an impact on how frequently gastrointestinal stents are used in most healthcare settings.

For instance, a survey by the Chinese Society of Digestive Endoscopy (CSDE) found that from 3,2 million treatments in 2019 to 1.5 million in 2020, China's GI endoscopic procedures had a considerable decline. Nearly all medical device markets had fully recovered by early 2021 from the pandemic's severe decline in device sales. However, the introduction of the Omicron model could endanger the expansion of sales of medical devices and lead to more cancellations of elective surgeries. The administration of booster doses and the current worldwide vaccination race will, however, lead to a market rebound in the years to come.

Global Gastrointestinal Stent Market Segmentation

By Product

Biliary Stents
Duodenal Stents
Colonics Stents
Pancreatic Stents
Esophageal Stents

By Material

Self-expanding Metal Stents
Plastic Stents

By Application

Biliary Diseases
Irritable Bowel Syndrome
Gastrointestinal Cancers

By End User

Hospitals & Clinics
Ambulatory Surgical Centers

Procure Complete Report (pdf with Insights, Charts, Tables, and Figures) https://www.globalinsightservices.com/checkout/single_user/GIS10289/utm_source=pranalipawar&utm_medium=Openpr&utm_campaign=06122023

About Global Insight Services:

Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.

Contact Us:

Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: info@globalinsightservices.com
Phone: +1-833-761-1700
Website: https://www.globalinsightservices.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Gastrointestinal Stent Market Is At A rate of 5.5% from 2022 - 2032 | Merit Medical Systems, Cantel Medical, Taewoong Medical here

News-ID: 3316536 • Views:

More Releases from Global Insight Services

Immuno Oncology Drugs Market Projected to Reach $634.1 Billion by 2034, Growing at 17.5% CAGR | Overall Study Report
Immuno Oncology Drugs Market Projected to Reach $634.1 Billion by 2034, Growing …
The Immuno Oncology Drugs Market is rapidly emerging as a transformative segment in the global healthcare industry. These drugs harness the body's immune system to identify and attack cancer cells, offering innovative treatment alternatives to traditional chemotherapy and radiation therapies. Immuno-oncology therapies include monoclonal antibodies, checkpoint inhibitors, cancer vaccines, and cell-based therapies such as CAR-T cells. The growth of this market is primarily driven by advancements in biotechnology, an improved
GLP 1 Market Projected to Reach $221.8 Billion by 2034, Growing at 9% CAGR | Overall Study Report
GLP 1 Market Projected to Reach $221.8 Billion by 2034, Growing at 9% CAGR | Ove …
The GLP 1 Market is experiencing unprecedented growth, fueled by the rising prevalence of type 2 diabetes and obesity globally. GLP-1, or glucagon-like peptide-1 receptor agonists, represents a groundbreaking therapeutic class that improves insulin secretion, reduces glucagon production, and slows gastric emptying. These mechanisms not only enhance glycemic control but also support weight management, making GLP-1 therapies a preferred choice among healthcare providers and patients alike. Over the years, the
Autonomous Bus Market to Expand to $11.6 Billion by 2034, Advancing at 18.8% CAGR | Key Players: EasyMile, Navya, Aurrigo
Autonomous Bus Market to Expand to $11.6 Billion by 2034, Advancing at 18.8% CAG …
Market Overview Autonomous Bus Market is revolutionizing the future of urban mobility through advanced automation technologies. Valued at $2.1 billion in 2024, the market is projected to reach $11.6 billion by 2034, expanding at a strong CAGR of 18.8%. This market focuses on the development and deployment of self-driving buses equipped with cutting-edge sensors, artificial intelligence, and vehicle-to-everything (V2X) communication systems. These buses are designed to improve road safety, enhance passenger
Automotive Tire Market to Attain $976.7 Billion by 2034, Growing at 9.2% CAGR | Key Players: Apollo Tyres, Nokian Tyres, Hankook Tire
Automotive Tire Market to Attain $976.7 Billion by 2034, Growing at 9.2% CAGR | …
Market Overview Automotive Tire Market is experiencing remarkable growth as the industry embraces innovation, sustainability, and digital transformation. Valued at $406 billion in 2024, the market is projected to soar to $976.7 billion by 2034, reflecting a CAGR of 9.2%. This expansion is primarily driven by the surge in global vehicle production, growing consumer preference for durable and high-performance tires, and the increasing adoption of smart tire technologies. The Automotive Tire

All 5 Releases


More Releases for Stent

Airway Stent Lung Stent Market Size 2024 to 2031.
Market Overview and Report Coverage An airway stent, also known as a lung stent, is a medical device used to open up blocked airways in the lungs. It is typically used in patients with conditions such as tracheal or bronchial stenosis, tumors, or strictures. The global airway stent lung stent market is expected to grow at a CAGR of 6.10% during the forecasted period. The future outlook for the airway stent lung
Airway Stent and Lung Stent Market Revenue Surges: Acumen Research Projection
The airway stent/lung stent market is witnessing a significant surge in revenue, projected to increase by USD 204.4 million by 2032. This growth is driven by a Compound Annual Growth Rate (CAGR) of 6.3% from 2023 to 2032. This article delves into the various facets of the market, including regional dominance, segment growth, and the underlying factors fueling this expansion. Market Revenue Growth The global airway stent/lung stent market is on an
Gel Stent Market Will Generate Booming Growth Opportunities to 2032 | Clinical P …
The latest Global Gel Stent Market research report 2022 provides detailed information about the market overview, prevalent trends, demand, and recent developments impacting the market growth during the upcoming years. The Gel Stent market report also covers the size, share, potential growth, and industry strategy followed by prominent players. This report also includes profiles for major companies within the market. There is wide acceptance of Gel Stent across the buyers' segments and this has been driving the
Gel Stent Market To Offer Lucrative Growth Opportunities to 2032 | Clinical Phas …
The global Gel Stent market research report offers domain wherein 2020 is historic period, 2021 is the base year, and 2022 to 2032 is forecast period. The wide application portfolio of Gel Stent is one of factors driving the growth of domain worldwide. The global market is moderately competitive with a blend of global and regional players. The industry players invest significantly in R&D to enhance their offerings. The entire
Global Evar Stent Grafts Market, Global Evar Stent Grafts Industry, Covid-19 Imp …
The aortic-aneurysm is a swelling & dilation the wall of blood-vessel, in general an artery, owing to weakness or degeneration, which develops in the segment of artery wall. Endovascular-aneurysm-repair or EVAR contains the conveying of implant in the aneurysm through small-groin incisions with X-rays to guide the graft into place. EVAR is an ideal treatment option for the aortic aneurysm considering to its advantages over the open surgery. Some of
Airway Stent/Lung Stent Market Size, Share, Trends & Forecast 2019-2025
The airway stent/lung stent market is forecast to grow at a CAGR of 5.8% attributed to the increasing adoption of bronchial stents in the treatment of lung cancer and other chronic respiratory diseases. The airway invasion is common in the patient diagnosed with lung cancer. These patients may develop stridor, intractable cough, post obstructive, dyspnea, hemorrhage, pneumonia and intractable cough due to tracheobronchial tumor extension. The optimal management of patients